PMS Relief F6: PMS with poor circulation, irregular period, infertility, headache, obstructed fallopian tubes, dizziness, coronary heart diseases, gastritis, kidney problems, sinus trouble, warts, leg and lower back pain or trauma.

1. PMS: 142 patients took F6 for up to 8 weeks and 72 were cured (50.70 percent), 16 significantly improved (11.26 percent), 41 improved (28.87 percent) and 13 did not improve (9.15 percent).

2. Excessive periods: 250 patients took F6 and only 24 did not improve. Most patients did have more bleeding in the first or two days but soon completely stopped.

3. Abnormal vaginal bleeding: 497 patients with abnormal vaginal bleeding took F6 for up to four months and 208 were cured (41.85 percent), 234 significantly improved (47.08 percent), 15 improved (3.01 percent) and 40 did not improve (8.04 percent).

4. Obstructed fallopian tube: 109 patients took F6 for up to 12 months and 58 were became pregnant (53.70 percent). Another 85 women with ovary tract blockage took F6 for three months and 48 cured with no blockage (56.47 percent), 25 improved (29.41 percent) and 12 did not improve (14.11 percent).

5. Headaches: 158 various headaches patients from three studies took F6 and 53 were cured (33.54 percent), 77 improved (48.73 percent), 19 improved (12.02 percent) and 9 did not.

6. Senile dizziness: 45 seniors took F6 and 15 were cured, 28 improved and 2 did not. The total effective rate was 95 percent.

7. Coronary heart disease: 868 patients from two reports took F6 or its modification for up to a month and only 6 did not improve. Total effectiveness rate was 99.3 percent.

8. Gastritis: 52 patients took F6 or its modification for three months and seven were cured (13.46 percent), 35 significantly improved (67.30 percent), 10 improved

9. Chronic kidney infection: 33 severe chronic kidney infection patients who had tried regular medicine with little effect took F6 or its modification and the total effective rate was 39.4 percent. 70 patients with abnormal HP were divided evenly into a comparison group taking regular western medicine and a treatment group taking F6. In the treatment group: 3 complete remissions, 25 partial remissions, 5 improved and 2 did not improve. Total remission rate was 80 percent in the treatment group, significantly better than the comparison group. There were significant differences between two groups, all P<0.01 or 0.05.

10. Warts: 125 patients from four reports took F6 for up to 30 days and 93 were cured (74.4 percent), 13 significantly improved (10.4 percent), 7 improved (5.6 percent) and 12 did not (9.6 percent).

11. Trauma: 240 patients with histories from two hours to 125 days took F6 or its modifications for a month and 218 were cured (90.83 percent) and 22 did not improve. Another report of 500 acute soft tissue injury patients who applied F6 externally after acupuncture treatment found 470 were cured (94 percent), 29 improved (5.8 percent) and one did not.